Anumana, Inc., a leader in cardiovascular AI, today announced U.S. Food and Drug Administration (FDA) clearance of its ECG-AI (TM) algorithm for cardiac amyloidosis (CA) -- the first and only cleared ...
In a future perhaps not too far away, artificial intelligence and its subfield of machine learning (ML) tools and models, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results